A spokesman for the Ministry of Health of Russia Oleg Salagaev reported initiation Office tightening penalties for overcharging for vital medicines. The proposed bill proposes to give the agency the authority to Roszdravnadzor administrative decisions on the suspension and revocation of licenses in case of violation of licensing requirements.
«Russian Health Minister Veronika Skvortsova was instructed to prepare a bill to strengthen the responsibility of pharmaceutical companies in case of unjustified increase of prices for these products up to the termination and withdrawal of licenses. The largest price increase was recorded in the drugs low (up to 50 rubles.) And medium (50 to 500 rubles.) Price categories – 11.7% and 5.7%, respectively. The level of prices for vital and essential drugs worth more than 500 rubles. in the current year increased by 3.5% “- leads the” Interfax “the words of Mr. greenhorn.
Previously published rating Roszdravnadzor pharmaceutical manufacturers, the quality of products which in the first half of this year received the largest number of complaints. Most drugs have rejected a series of “Murom Instrument-Making Plant”. Experts say that because of the volume of spot checks of substandard products in the market twice a detectable Roszdravnadzor. They suggest that this figure could still rise after a possible legalization of parallel importation of drugs.
For more information about the ranking Roszdravnadzor read the material “b” “Tablets emissions.”
No comments:
Post a Comment